Literature DB >> 16327961

Hemangiomas of infancy: clinical and biological characteristics.

Kara N Smolinski1, Albert C Yan.   

Abstract

Hemangiomas of infancy are common in the general pediatric population, are usually easily diagnosed, and generally do not require treatment. However, a small but significant percentage of hemangiomas of infancy may develop complications, including infection or ulceration. In addition, hemangiomas located in some anatomic regions may be associated with other anomalies and therefore require more careful monitoring and earlier intervention to prevent permanent sequelae. This review focuses on distinguishing hemangiomas from vascular malformations and delineates the natural history of hemangiomas of infancy, with an emphasis on identifying those hemangiomas that require additional evaluation and closer follow-up. Current treatment modalities, including the use of systemic steroids and the pulsed-dye laser, are discussed. In addition, several conditions that often present with cutaneous hemangiomas are described, including PHACES syndrome and neonatal hemangiomatosis. Finally, an assessment is made of the current understanding of the biology of hemangioma proliferation and involution, including the role of endothelial growth factors and GLUT1, a new marker for hemangiomas of infancy. Clin Pediatr. 2005;44:747-766.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16327961     DOI: 10.1177/000992280504400902

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  17 in total

1.  Subtotal splenic embolization is a safe and effective treatment for isolated splenic vascular tumors associated with consumptive coagulopathy.

Authors:  Eric H Raabe; Jeffrey R Keefer; Sally E Mitchell; Kelvin Hong; Marc DiFazio; John J Strouse
Journal:  J Pediatr Hematol Oncol       Date:  2011-07       Impact factor: 1.289

2.  Circulating Levels of Vascular Endothelial Growth Factor and Basic Fibroblastic Growth Factor in Infantile Hemangioma Versus Vascular Malformations.

Authors:  Nehal M El-Raggal; Rania A El-Farrash; Abeer A Saad; Enas A S Attia; Hatem A Saafan; Ibrahim S Shaaban
Journal:  Clin Appl Thromb Hemost       Date:  2017-06-08       Impact factor: 2.389

Review 3.  Vascular anomalies of the upper extremity.

Authors:  Benjamin J Jacobs; Alex Anzarut; Sara Guerra; Gayle Gordillo; Joseph E Imbriglia
Journal:  J Hand Surg Am       Date:  2010-10       Impact factor: 2.230

4.  One Possible Mechanism of Pulsed Dye Laser Treatment on Infantile Hemangioma: Induction of Endothelial Apoptosis and Serum vascular endothelial growth factor (VEGF) Level Changes.

Authors:  Yongqian Cao; Fagang Wang; Qingwei Jia; Rongjian Xu; Wei Dang; Qing Chen; Li Lin; Yibing Wang
Journal:  J Lasers Med Sci       Date:  2014

5.  Effect of laser therapy on plasma expression of VEGF and bFGF in infants with cutaneous hemangioma.

Authors:  Fagang Wang; Rongjian Xu; Qian Xu; Yongqian Cao; Li Lin; Wei Dang
Journal:  Oncol Lett       Date:  2017-01-25       Impact factor: 2.967

6.  Serum Basic Fibroblastic Growth Factor Levels in Children with Infantile Hemangioma.

Authors:  Hikmet Gulsah Tanyildiz; Emel Cabi Unal; Hafize Gokce; Gulsan Yavuz; Nurdan Tacyildiz; Handan Dincaslan; Ceyda Gurman; Zeynep Biyikli
Journal:  Indian J Pediatr       Date:  2016-01-27       Impact factor: 1.967

7.  Effect of continuous positive airway pressure therapy on a large hemangioma complicated with obstructive sleep apnea syndrome: a case report.

Authors:  Maria Antoniadou; Paschalis Steiropoulos; Evangelia Serasli; Venetia Tsara
Journal:  J Med Case Rep       Date:  2010-08-12

Review 8.  Interventions for infantile haemangiomas of the skin.

Authors:  Monica Novoa; Eulalia Baselga; Sandra Beltran; Lucia Giraldo; Ali Shahbaz; Hector Pardo-Hernandez; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2018-04-18

9.  Identification of novel potential biomarkers in infantile hemangioma via weighted gene co-expression network analysis.

Authors:  Bin Xie; Xiongming Zhou; Jiaxuan Qiu
Journal:  BMC Pediatr       Date:  2022-05-01       Impact factor: 2.567

10.  Mechanisms of propranolol action in infantile hemangioma.

Authors:  Jina Jy Kum; Zia A Khan
Journal:  Dermatoendocrinol       Date:  2015-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.